Huaren Pharmaceutical (300110.SZ) has dismissed Hong Liang from the position of CEO.

Huaren Pharmaceutical (300110.SZ) issued an announcement, stating that on December 27, 2024, the company held the sixth (interim) meeting of the eighth board of directors, where they approved the motion for the dismissal of the company's CEO. According to the company's needs for operational management, and after review by the board of directors' nomination committee, the board of directors agreed to dismiss Mr. Hong Liang from his position as CEO, with the dismissal taking effect from the date of the board meeting. After the dismissal, Mr. Hong Liang will no longer hold any position within the company, and this dismissal will not have any adverse effects on the company's normal operational activities.